Introduction

Carbohydrates often get blamed for everything in Type 2 Diabetes from high sugars to weight gain to insulin resistance. Somewhere along the way, this has led to a common belief:

“If carbs are the problem, removing them completely must be the solution.”

This is where the confusion between low-carb and keto begins.

While both approaches reduce carbohydrate intake, they operate very differently at a metabolic level and their long-term effects on glucose control, gut health, lipid metabolism, and sustainability are far from the same.

Let’s break this down scientifically without fear, fad, or food guilt.

Definitions and Macronutrient Composition

Low-Carbohydrate Diet

A low-carbohydrate diet typically provides:

• Carbohydrates: ~100–130 g/day (or 26–45% of total energy)

• Protein: Moderate to high (20–30%)

• Fat: Balanced, primarily unsaturated

This approach emphasizes carbohydrate quality rather than elimination, allowing inclusion of:

• Whole grains (controlled portions)

• Low-glycaemic fruits

• Pulses and legumes

• Non-starchy vegetables

Ketogenic Diet

A ketogenic diet is characterized by severe carbohydrate restriction:

• Carbohydrates: <20–30 g/day (<5–10% of energy)

• Fat: 70–80%

• Protein: Moderate

The objective is to induce nutritional ketosis, defined by elevated circulating ketone bodies (β-hydroxybutyrate ≥0.5 mmol/L), shifting primary fuel utilization from glucose to fatty acids.

Metabolic Mechanisms

Low-Carbohydrate Diet: Metabolic Effects

• Reduces postprandial glucose excursions

• Lowers insulin demand

• Improves hepatic and peripheral insulin sensitivity

• Preserves endogenous glucose regulation

• Supports incretin response through mixed macronutrient meals

Importantly, glucose availability is reduced without complete suppression of glycolytic pathways.

Ketogenic Diet: Metabolic Effects

• Near-total depletion of hepatic glycogen

• Increased fatty acid oxidation

• Elevated ketogenesis

• Suppression of insulin secretion

• Increased glucagon-to-insulin ratio

While glycaemic values may improve initially, metabolic flexibility is significantly reduced.

Clinical Outcomes in Type 2 Diabetes

Glycaemic Control

Short-term findings (3–6 months):

• Both low-carb and keto diets demonstrate reductions in HbA1c

• Rapid glucose lowering seen with keto due to carbohydrate elimination

Long-term findings (≥12 months):

• Low-carb diets maintain glycaemic improvements

• Keto diets show declining adherence and partial glycaemic relapse

Multiple trials indicate that glycaemic durability is superior with moderate carbohydrate restriction.

Time in Range (TIR)

Low-carbohydrate diets:

• Improve postprandial variability

• Reduce glycaemic excursions

• Support sustained TIR improvement

Ketogenic diets:

• Reduce hyperglycaemia

• Increase risk of hypoglycaemia, particularly in insulin or sulfonylurea users

Gut Microbiota and Fiber Considerations

Low-Carbohydrate Diet

• Maintains fermentable fiber intake

• Supports short-chain fatty acid (SCFA) production

• Preserves microbial diversity

• Enhances intestinal barrier integrity

Ketogenic Diet

• Markedly reduced fiber intake

• Decreased butyrate-producing bacteria

• Increased risk of dysbiosis

• Potential pro-inflammatory gut environment

Gut health impairment remains a major limitation of prolonged ketogenic diets.

Lipid Metabolism and Cardiovascular Risk

Low-carbohydrate diets typically:

• Improve triglyceride levels

• Increase HDL cholesterol

• Maintain LDL stability when fats are unsaturated

Ketogenic diets may:

• Elevate LDL-C in hyper-responders

• Increase ApoB and small dense LDL

• Worsen cardiovascular risk profile in susceptible individuals

This is clinically significant in T2DM populations with pre-existing cardiometabolic risk.

Hypoglycaemia Risk and Medication Interaction

Ketogenic diets significantly increase hypoglycaemia risk due to:

• Reduced hepatic glucose output

• Ongoing medication effects

• Impaired counter-regulatory response

Low-carbohydrate diets allow:

• Safer medication titration

• Reduced glycaemic volatility

• Lower incidence of severe hypoglycaemic events

Sustainability and Behavioral Adherence

Low-carbohydrate diets demonstrate:

• Higher long-term adherence

• Cultural adaptability (including Indian dietary patterns)

• Lower relapse and weight regain rates

Ketogenic diets show:

• High attrition rates

• Social and psychological burden

• Frequent rebound hyperglycaemia post discontinuation

Clinical Consensus and Practical Application

Current evidence supports:

 Moderate carbohydrate restriction as a first-line nutritional strategy in T2DM

Ketogenic diets may be considered only:

• Short term

• Under medical supervision

• With close glucose and medication monitoring

They are not recommended as a long-term dietary therapy for most individuals with Type 2 Diabetes.

Key Clinical Takeaway

Type 2 Diabetes management benefits more from:

• Carbohydrate moderation rather than elimination

• Fiber preservation

• Metabolic flexibility

• Sustainable behavioral adherence

Long-term glycaemic control is achieved not through metabolic extremes, but through structured, physiologically supportive nutrition strategies.

Final Note

Any dietary intervention in T2DM should be individualized, regularly reviewed, and integrated with pharmacotherapy, physical activity, and metabolic monitoring to ensure safety and durability of outcomes.